Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Novartis names Firmenich CEO as chairman designate of Sandoz

Published by Uma Rajagopal

Posted on February 20, 2023

1 min read

· Last updated: February 2, 2026

Add as preferred source on Google

The image features the Novartis logo at their new factory, relevant to the announcement of Gilbert Ghostine as chairman-designate of Sandoz, Novartis' generics unit, highlighting significant corporate leadership changes.

Appointment management financial services corporate governance

Global Banking & Finance Awards 2026 — Call for Entries

ZURICH (Reuters) – Novartis on Monday announced the appointment of Gilbert Ghostine as chairman-designate of Sandoz, the generics unit Novartis wants to spin off later this year. Ghostine has been CEO of Geneva-based Firmenich, the world’s largest privately owned perfume and taste company, since 2014. He will become the chairman of the new board at […]

ZURICH (Reuters) – Novartis on Monday announced the appointment of Gilbert Ghostine as chairman-designate of Sandoz, the generics unit Novartis wants to spin off later this year.

Ghostine has been CEO of Geneva-based Firmenich, the world’s largest privately owned perfume and taste company, since 2014.

He will become the chairman of the new board at Sandoz, which is to be formed after its spin-off from Novartis in the second half of 2023, subject to final Novartis Board of Directors and shareholder approvals.

(Reporting by John Revill; Editing by Paul Carrel)

Frequently Asked Questions

What is a chairman?

A chairman is the head of a board of directors in a company, responsible for overseeing meetings and ensuring that the board functions effectively.

What is a spin-off?

A spin-off is a corporate action where a company creates a new independent company by selling or distributing new shares, allowing it to focus on its core business.

What are generics?

Generics are medications that are equivalent to brand-name drugs in dosage, strength, and administration but are sold under their chemical names without branding.

What is a board of directors?

A board of directors is a group of individuals elected to represent shareholders and oversee the activities and governance of a corporation.

What is corporate governance?

Corporate governance refers to the systems, principles, and processes by which a company is directed and controlled, ensuring accountability and transparency.

Novartis names Firmenich CEO as chairman designate of Sandoz

Frequently Asked Questions

Tags

Related Articles

Why Curiosity Is the Hidden Engine Behind Every Big Idea

The Silent Shift Reshaping Global Finance

The Invisible Forces Rewiring Global Finance—And Why the Shift Is Already Underway

The Global Finance Reset No One Is Talking About—But Everyone Is Feeling

The Financial Trend Hiding in Plain Sight—Why Everything Feels the Same, But Isn’t

The Financial System’s New Rhythm—Why Change Is Happening Without Disruption

More from Top Stories